Venrock Healthcare Reports a $1.2 Million KALV Buy

Steve Strazza
February 8, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The most significant transaction on today’s list comes in a Form 4 filing by Venrock Healthcare Capital Partners.

The firm reported a purchase of roughly $1.2 million in KalVista Pharmaceuticals Inc $KALV.

Article Sales Message

Know the trading behavior of …

  • Senators
  • House Of Representatives
  • C-Suite Executives
  • Hedge Fund Managers
  • Other Big-Power Players

Our experienced team of analysts work through the Form 4, 13D and 13G filings to provide you a list of the best trade ideas.

You need to have a subscription to access this content in full.

Log in or subscribe
Filed Under: